Small Animal Imaging (In-Vivo) Market Outlook From 2026 To 2030: Key Growth Factors And Future Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Small Animal Imaging (In-Vivo) Market Revenue Growth On Track For A 11.8% CAGR Through 2030
The small animal imaging (in-vivo) market has experienced rapid expansion in recent years. This market is projected to grow from $3.15 billion in 2025 to $3.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.4%. The historical increase in this market can be attributed to several factors, including an uptick in preclinical research activities, a rise in drug discovery investments, expanded funding for academic research, the increasing adoption of animal models in disease studies, and the availability of advanced imaging modalities.
The small animal imaging (in-vivo) market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $5.53 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by factors such as the increasing need for precision medicine research tools, rising investments in translational research, the broadening of oncology and neurological studies, the growing adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Prominent trends observed in this period include the increased adoption of multimodal imaging systems, a rise in the use of non-invasive in vivo imaging techniques, the expanding integration of AI-based image analysis, the extension of longitudinal disease monitoring studies, and an enhanced emphasis on high-resolution imaging capabilities.
Get A Free Sample Report With In-Depth Market Insights:
Small Animal Imaging (In-Vivo) Market Development Factors: What’s Supporting Demand?
The small animal imaging (in vivo) market is projected to grow as a result of increasing spending in the healthcare sector. Healthcare expenditure refers to the total public and private costs for health care as a percentage of GDP. The rise in healthcare expenditure along with greater healthcare awareness promotes the idea of self-care management, a practice where PET equipment is utilized in techniques such as small animal imaging. Small animal imaging (in vivo) benefits the healthcare sector by allowing for noninvasive, real-time visualization of biological processes, accelerating the development of drugs, improving comprehension of diseases, and assisting in the creation of more effective therapies. For instance, in May 2024, a report from the Office for National Statistics, a UK-based government statistical organization, revealed that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Hence, the increasing financial investment in the healthcare sector is fueling the expansion of the small animal imaging (in-vivo) market.
Small Animal Imaging (In-Vivo) Market Segment Landscape: Which Areas Lead Development?
The small animal imaging (in-vivo) market covered in this report is segmented –
1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
Subsegments:
1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents
2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers
4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems
Small Animal Imaging (In-Vivo) Market Transformation Trends: What Innovations Are Driving Change?
Major companies within the small animal imaging (In-Vivo) market are increasingly prioritizing sophisticated in vivo imaging software platforms, such as modules for real-time kinetic analysis. This emphasis aims to address the growing need for more precise, quantitative, and efficient preclinical research in areas like oncology and neuroscience. These platforms facilitate the continuous capture and automated examination of dynamic bioluminescent (BLI) signals across time, diverging from conventional static single-timepoint observations. This approach results in more comprehensive kinetic curves, enhanced reproducibility, and improved identification of crucial peak signal stages. An illustrative example occurred in April 2024, when Spectral Instruments Imaging, a US-based preclinical imaging technology company, unveiled Aura 4.5. This release represents the newest iteration of its in vivo imaging software. Aura 4.5 incorporates a Kinetics mode, which allows for automated, real-time collection of bioluminescent signals throughout their entire time course, encompassing the rise, plateau, and decay phases. Subsequently, the software pinpoints and reports the peak bioluminescent intensity, thereby assisting researchers in optimizing sensitivity and biological accuracy. Furthermore, it streamlines the process of data acquisition and minimizes the need for manual intervention, consequently boosting workflow efficiency for longitudinal investigations. This feature-rich enhancement proves particularly beneficial for longitudinal, time-sensitive studies, including pharmacokinetics, gene expression, or infection models.
Small Animal Imaging (In-Vivo) Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation
View The Full Small Animal Imaging (In-Vivo) Market Report:
Small Animal Imaging (In-Vivo) Market Geographic Distribution And Regional Opportunities
North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
